Metabolic Mapping and Cardiac Resynchronization
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/30/2018 |
| Start Date: | August 20, 2018 |
| End Date: | December 2022 |
| Contact: | Tonya Sands |
| Email: | sands.tonya@mayo.edu |
| Phone: | 507-538-5427 |
Metabolic Mapping and Cardiac Resynchronization (Aim 1)
The purpose of this study is to gather information on the safety and effectiveness of cardiac
resynchronization therapy (CRT) in patients who have mild heart failure (HF) and left bundle
branch block (LBBB).
resynchronization therapy (CRT) in patients who have mild heart failure (HF) and left bundle
branch block (LBBB).
Inclusion Criteria:
- LVEF 36%-50%
- NYHA class I-II
- QRS duration of ≥130ms
- Left bundle branch block (LBBB)
- Patient is able to receive a transvenous pectoral CRT-P implant
- Patient is able to sign informed consent
- Two echocardiograms are required to confirm a stable reduced LVEF
Exclusion Criteria:
- Advanced comorbid conditions with life expectancy <1 year
- Patient is <18 of years of age
- Patient has recent MI <40 days, CABG or coronary intervention <90 days
- Patient has atrial fibrillation
- Patient has a CRT-P, ICD or CRT-D device
- Female patients who is pregnant or not on a reliable form of birth control. Women of
childbearing potential are required to have negative pregnancy test within the 7 days
prior to device implant
- Unwilling or unable to return for required follow-up visits
- Patient decides study participation is cost-prohibited
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Phone: 507-293-2762
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
